Skip to content
Low Dose GLP-1Providers

Provider review

Mondae review

Prices by the dose you start at, then holds it.

Pick a starting dose and a pharmacy and the price is set there; titrating up does not move it. The lowest semaglutide rung is 0.2 mg and it is the cheapest thing on the site.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.

Price as published

Mondae

$115/mo semaglutide at a 0.2 mg start

Vs median
$54/mo below the $169 median
Market
$59–$1300/mo across 242 of 373
Structure
Quotes off the lowest dose
Dispensed
Compounded by Patient-selectable: Boudreaux, Rush, Hallandale, Greenwich, Align, VialsRx

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

Take a low dose here and you pay less for it — this is the clearest answer on the site. Mondae sets your price from the dose you start at, publishes every combination before you pay, and then holds that price as you titrate up: "Your dose may increase, but your price is fixed." Its cheapest semaglutide rung is a real 0.2 mg start, priced below everything else it sells. It also lets you choose your own compounding pharmacy at checkout and prints each one's additive beside the name, which nothing else here does, and it serves all 50 states. Two cautions. The lock is tied to continuous membership rather than to you — the rate holds "as long as your membership remains active", so a break in treatment is not free. And the figures move between pages: the homepage quotes the three-month rate while the product cards quote the monthly one, so the number you remember may not be the one you are charged.

Visit Mondae

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You intend to start low and stay low — the cheapest rung is a real 0.2 mg start, priced below everything else here
  • You expect to titrate up and want the rate you started at to hold while you do
  • You want to choose your own compounding pharmacy, and to know what each one adds to the formulation
  • You want every combination of dose, pharmacy and plan length costed before you pay

Look elsewhere if

  • You expect the locked rate to survive a break in treatment. It holds while the membership is active, and not afterwards
  • You are working from the homepage figure — that is the three-month rate, and the product cards quote a different one
  • You want a LegitScript identifier before ordering; none is published
  • You want a price you can read without scripts running — the configurator computes it in the browser

What it actually costs

Price as published

Compounded semaglutide, one-month plan, priced by the dose you start at and the pharmacy you pick (cheapest to dearest): 0.2 mg $115–$150, 0.6 mg $125–$155, 1.1 mg $135–$160, 1.9 mg $140–$165, 2.1 mg $145–$170, 2.3 mg $150–$199 · compounded tirzepatide, one-month: 1.5 mg $145–$165, 3 mg $150–$170, 6 mg $155–$180, 9 mg $165–$185, 11 mg $170–$195, 13.5 mg $180–$229 · Boudreaux is the cheapest pharmacy at every rung · three-month blocks lower it slightly — semaglutide 0.2 mg at Boudreaux is $338 for three months ($113/mo) against $115 month to month · "Billed monthly", with 1-month and 3-month plan lengths · the rate is then held: "Choose the dose you start at. Your dose may increase, but your price is fixed" and "your rate stays the same as long as your membership remains active" · the homepage advertises "Prices start from $113", the three-month rate, while the product cards say "From $115" and "From $145"

Vs median
$54/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
Market
$59–$1300/mo is the full published spread in our ranking
Structure
Quotes off the lowest dose

States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.

36 of the 373 programs we track price a small dose this way. The starting dose sets the rate and the rate is then held as the dose climbs, so a reader who starts at the lowest rung pays the lowest price and keeps it. The whole matrix of dose, pharmacy and plan length is published before payment. The lock depends on the membership staying active.

Visit Mondae

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not included
Labs
Not required
Pricing
Varies by dose, plan or tier
Price last updated
August 2026

What it does well

  • Prices by the dose you start at, and the cheapest rung is a genuine 0.2 mg semaglutide start — the lowest-priced thing it sells
  • Holds that rate as the dose is titrated up: "Your dose may increase, but your price is fixed"
  • The only provider here that lets a patient choose their own compounding pharmacy at checkout, and it prints each pharmacy's additive next to the name — glycine, B6, B12, B3, or none
  • Publishes a complete price × starting-dose × pharmacy matrix, all of it reachable before payment
  • Names all six selectable pharmacies rather than referring to "licensed US pharmacies"
  • Available in all 50 states, stated in the homepage FAQ
  • No membership fee, with 1:1 provider guidance stated as included

Pharmacy, labs and oversight

Mondae dispenses through a Patient-selectable: Boudreaux, Rush, Hallandale, Greenwich, Align, VialsRx facility. No bloodwork is required before you start. A clinician review is included in the price.

Transparency check

3 of 4 published openly

What Mondae publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
Published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
Published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

Mondae sells compounded semaglutide and compounded tirzepatide through a configurator: you choose the dose you start at, the compounding pharmacy that fills it and a one- or three-month plan, and the price follows those three choices. Its structural promise is that the starting price then holds — "The price you start with is the price you keep for life. While many programs increase pricing as doses increase, your rate stays the same as long as your membership remains active." Six pharmacies are selectable at checkout, each with its additive published: Boudreaux (glycine), Rush (B6), Hallandale (none), Greenwich (B12), Align (B12/B3) and VialsRx (B12). It says it is available in all 50 states and charges no membership fee.

The honest cons

The price lock is tied to continuous membership rather than to the patient: "your rate stays the same as long as your membership remains active". A break in treatment is not free
  • Three current figures describe the same entry point: the homepage says "Prices start from $113" (the three-month rate) while the product cards say "From $115" and "From $145" (the one-month rates)
  • The chart illustrating the price-lock claim is footnoted "This chart is a stylized representation and does not depict an actual treatment plan", so the illustration is not evidence for the promise above it
  • With scripts blocked the sentence reads "your price is fixed at $NNN" and the page shows a stale $600 / $537 / $179 — no real price is visible
  • A seventh pharmacy, "Revive", is priced in the site's own data but is not offered as a choice on the page
  • No LegitScript identifier is published
  • Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Visit Mondae

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Mondae is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Where this sits

#139 of 373

Ordered with the companies that pay us first, and Mondae is not one of them. A disclosed partition, not a score.

Compare all 373 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Visit Mondae

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

Elara MD

$249/mo at 0.2 mg/wk semaglutide

Vs median
$80/mo above the $169 median
Market
$59–$1300/mo across 242 of 373
Structure
Quotes off the lowest dose
Dispensed
Compounded, 503A pharmacy

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the Elara MD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.